tDCS Device Models
  • Price
  • Customer Rating
  • Max Current
  • Max Voltage
  • LCD Display
  • Timer
  • Auto Ramp Up / Down
  • Low Battery
  • Sham (Placebo)
  • CE-Marked
  • Medical Grade
  • FDA-Cleared
  • Waveforms
  • More Info

Table reviews and pricing updated live*

What is important in a tDCS device

    The 5 most important features in a choosing a tDCS device are
  1. Build Quality - Is the device you are using Medical Grade
  2. Accurate Current Delivery - Does the device have enough power (minimum 20 volts max output) to provide an accurate current delivery with varying skin resistances
  3. Automatic Current Ramp Up / Down - Does the device automatically increase and decrease the current to allow your neurons to accomodate to the sensation of stimulation
  4. Built-in Timer - Does the device automatically ramp down and shut off after your pre-set amount of time
  5. Low Battery Indicator - Does the device let you know when the battery is too low to complete a session

Most people who want to use tDCS for research, treatment or performance enhancement want to reproduce a tDCS protocol that has been studied and published in a scientific paper. The right device, along with the correct electrodes and headgear, are critical for reproducibility. It is a mistake to assume that any device that provides stimulation is acceptable. With this in mind, Caputron has created the table above to help guide you through the important features.

Best Selling tDCS Devices of 2018

Choosing the best tDCS device can be tricky. View our best selling tDCS devices of 2018.

product image

Best Device of 2018: Activadose tDCS Starter Kit - Physician Recommended

Research tDCS Device Comparison Table - (Last Updated 2/8/18)

All research grade systems have timers, automatic ramp up/down, continuous impedenance monitoring, low battery indicator and are IEC 60601 safety and EMC compliant.

Device Maximum Output Voltage Output Current Adjustable Current Increment Max Timer Duration Output Current Monitoring Sham # Stimulation Channels Bi-channel Stimulation EEG Compatible # EEG Channels Programming Software MRI Compatible Trigger Regulatory (FDA,CE,International)
Soterix Medical 1X1 tDCS 40 V 0 - 2 mA 100 µA 40 min Yes Single/Double Blind 1 Yes * Yes ** 8 - 64 No Yes # Optional CE,International
Soterix Medical 1X1 tDCS-LTE 20 V 0 - 1.5 mA 100 µA 20 min Yes Single/Double Blind 1 Yes * Yes ** 8 - 64 No Yes # Optional CE,International
Soterix Medical 1X1 tES 0 - 2 mA 10 µA (across all waveforms) 40 min Yes Single/Double Blind 1 Yes * Yes ** 8 - 64 No Yes # Yes CE,International
Soterix Medical 1X1 Clinical Trials 20 V Customizable N/A Customizable N/A Triple Blind 1 Yes * Yes ** 8 - 64 No Yes # Optional CE,International
Activadose II 80 V 0 - 4 mA 100 µA 40 min Yes No 1 No No FDA
Neurocare DC-STIMULATOR ? 0 - 2 mA 250 µA 30 min No Yes 1 No 32 No Yes # Yes CE,International
Neurocare DC-STIMULATOR PLUS ? 0 - 4.5 mA 25 µA (sine) 30 min No Yes 1 No 32 No Yes # Yes CE,International
Newronika / HDCkit (HDCprog +HDCstim) 28 V 0.5- 1.5 mA 1 µA 20 min No Yes 1 No No Yes *** No Yes CE
E.M.S BrainSTIM 24 V 0.1- 5 mA 100 µA 60 min No Yes 1 No No Yes *** No Yes CE
Soterix Medical IontoDC 40 V 1- 2 mA 250 µA 40 min Yes No 1 No No No No No No FDA
Soterix Medical 4X1 30 V 0- 2 mA 100 µA 40 min Yes Yes 5 N/A Yes 8 - 256 No Yes # Yes CE,International
Soterix Medical MxN 30 V 0- 2.5 mA 10 µA (across all waveforms) 40 / 60 min Yes Yes 5, 9, 32 Yes 8 - 256 No Yes # Yes CE,International
Neuroelectrics STARSTIM 8 30 V 0- 2 mA 1 µA 60 min No Yes 8 Yes 8 Yes *** Yes # ? CE
Neuroelectrics / STARSTIM tCS 30 V 0- 2 mA 1 µA 60 min No Yes 8 No None Yes *** Yes # ? CE
  • * - with breakout box
  • ** -with separate connector cable
  • *** -stimulator settings transferred via BT through software installed on PC/MAC
  • # - separate accessory

Consumer vs Medical / Research tDCS Devices

Disclaimer: The information provided here is not medical or legal advice. It is not an endorsement of any device, application or use. It is based entirely on information in the listed publications and information from manufacturer websites.

What is consumer tDCS? Consumer tDCS devices are marketed directly towards users. They can be marketed simply as “tDCS” or for cognitive enhancement or for performance enhancement. They cannot be marketed for medical use, such as the treatment of a disease, since then they would be classified as medical devices. Once a consumer obtains a tDCS device, they can use their device for for any application. Consumer devices are cheaper then medical / research grade devices. The FDA has provided letters to companies like Thync and Halo; allowing them to market tDCS for consumer purposes without making claims on medical therapy.

What are the standards for Consumer tDCS? The quality of consumer tDCS devices varies. At the high end, devices such as Halo, Thync and ActivaDose are produced to the same standards as medical devices, they are just not cleared by the government for medical use and are not marketed by the companies for medical use. These products likely meet the “LOTES” guidelines. On the other extreme, there may be products that are not carefully designed or built. Poor design can mean things like not producing the correct output. Poor build simply means that products may be sent out with defects.

What is research grade tDCS? Research tDCS devices are those marketed for use in clinical trials. Research devices used in clinical trials must see the same design and manufacturing standards as clinical tDCS devices. This means, according to regulations in the US, Europe and other countries, devices tested on people need to be built to medical devices standards, even when they are not yet approved for use. For this reason, clinical and research grade tDCS devices are the same thing as far the devices themselves. The difference is simply how they are marketed. For example, the Soterix Medical 1x1 tDCS is marketed in the US for research but is approved and marketed in Europe for the treatment of depression, pain (migraine, fibromyalgia) and stroke rehabilitation.

What are the standards for Research and Medical grade tDCS? The standards that govern research and medical grade tDCS in the US are called FDA Quality Systems which rely on the rules by the IEEE organization. The comparable standards in Europe are part of the CE mark and relies on rules set by the IEC organization. But since the IEEE and IEC are almost identical, medical / research grade tDCS products usually meet standards across the US, Europe and other countries.

What is the difference in cost? Consumer devices range from about $80 to $500. Medical and research devices range from $300 to about $5,000 for top brand to over $10,000 for the more advanced High-Definition systems.

What about iontophoresis devices? An iontophoresis devices is cleared by the FDA or another country for the use of direct current stimulation to deliver ions or drugs to the body. When used without drugs, the delivery of ions is for all practical purposes the same thing as tDCS. The use of an iontophoresis device for tDCS treatment would be “off-label”.

What is HD-tDCS? HD-tDCS stands for High Definition transcranial Direct Current Stimulation. Regular tDCS uses relatively large electrodes (about 5x5 cm) while HD-tDCS uses relatively small electrodes (about 1x1 cm) which are gel filled. HD-tDCS is found only on Research / Clinical grade devices. HD-tDCS can be used with EEG to record brain activity.

Can the same device be a consumer and medical / research grade tDCS device? This can be complicated, but yes. The Thync device and the Fisher Wallace devices, neither of which are basic tDCS, have separate websites for consumer and medical use, but it's the identical device. Medical and research tDCS devices cannot be sold to consumers, though they can be provided via a medical care-giver. Bottom line, the devices listed below as Consumer can be bought by anyone, whereas the ones listed under Medical / Research, can only be bought by medical care-givers or researchers.

References

Limited output transcranial electrical stimulation (LOTES-2017): Engineering principles, regulatory statutes, and industry standards for wellness, over-the-counter, or prescription devices with low risk. Bikson M, Paneri B, Mourdoukoutas A, Esmaeilpour Z, Badran BW, Azzam R, Adair D, Datta A, Fang XH, Wingeier B, Chao D, Alonso-Alonso M, Lee K, Knotkova H, Woods AJ, Hagedorn D, Jeffery D, Giordano J, Tyler WJ. Brain Stimul. 2018 Jan - Feb;11(1):134-157. doi: 10.1016/j.brs.2017.10.012. Epub 2017 Oct 17.

A pragmatic analysis of the regulation of consumer transcranial direct current stimulation(TDCS) devices in the United States. Wexler A. J Law Biosci. 2015 Oct 12;2(3):669-696. eCollection 2015 Nov. PMID: 27774217

The off-label use, utility and potential value of tDCS in the clinical care of particular neuropsychiatric conditions. Bikson M, Paneri B, Giordano J. J Law Biosci. 2016 Sep 10;3(3):642-646. doi: 10.1093/jlb/lsw044. eCollection 2016 Dec. No abstract available. PMID: 28852542

Low intensity transcranial electric stimulation: Safety, ethical, legal regulatory and application guidelines. Antal A, Alekseichuk I, Bikson M, Brockmöller J, Brunoni AR, Chen R, Cohen LG, Dowthwaite G, Ellrich J, Flöel A, Fregni F, George MS, Hamilton R, Haueisen J, Herrmann CS, Hummel FC, Lefaucheur JP, Liebetanz D, Loo CK, McCaig CD, Miniussi C, Miranda PC, Moliadze V, Nitsche MA, Nowak R, Padberg F, Pascual-Leone A, Poppendieck W, Priori A, Rossi S, Rossini PM, Rothwell J, Rueger MA, Ruffini G, Schellhorn K, Siebner HR, Ugawa Y, Wexler A, Ziemann U, Hallett M, Paulus W. Clin Neurophysiol. 2017 Sep;128(9):1774-1809. doi: 10.1016/j.clinph.2017.06.001. Epub 2017 Jun 19. Review. PMID: 28709880

Safety of Transcranial Direct Current Stimulation: Evidence Based Update 2016. Bikson M, Grossman P, Thomas C, Zannou AL, Jiang J, Adnan T, Mourdoukoutas AP, Kronberg G, Truong D, Boggio P, Brunoni AR, Charvet L, Fregni F, Fritsch B, Gillick B, Hamilton RH, Hampstead BM, Jankord R, Kirton A, Knotkova H, Liebetanz D, Liu A, Loo C, Nitsche MA, Reis J, Richardson JD, Rotenberg A, Turkeltaub PE, Woods AJ. Brain Stimul. 2016 Sep-Oct;9(5):641-61. doi: 10.1016/j.brs.2016.06.004. Epub 2016 Jun 15. Review. PMID: 27372845

Outstanding questions concerning the regulation of cognitive enhancement devices. De Ridder D, Vanneste S, Focquaert F. J Law Biosci. 2014 Sep 19;1(3):316-321. eCollection 2014 Sep. PMID: 27774170

Early adopters of the magical thinking cap: a study on do-it-yourself (DIY) transcranial direct current stimulation (tDCS) user community. Jwa A. J Law Biosci. 2015 Jun 2;2(2):292-335. eCollection 2015 Jul. PMID: 2777419

A technical guide to tDCS, and related non-invasive brain stimulation tools. Woods AJ, Antal A, Bikson M, Boggio PS, Brunoni AR, Celnik P, Cohen LG, Fregni F, Herrmann CS, Kappenman ES, Knotkova H, Liebetanz D, Miniussi C, Miranda PC, Paulus W, Priori A, Reato D, Stagg C, Wenderoth N, Nitsche MA. Clin Neurophysiol. 2016 Feb;127(2):1031-1048. doi: 10.1016/j.clinph.2015.11.012. Epub 2015 Nov 22. Review. PMID: 26652115

Noninvasive techniques for probing neurocircuitry and treating illness: vagus nerve stimulation(VNS), transcranial magnetic stimulation (TMS) and transcranial direct current stimulation(tDCS). George MS, Aston-Jones G. Neuropsychopharmacology. 2010 Jan;35(1):301-16. doi: 10.1038/npp.2009.87. Review. PMID: 19693003

Regulatory Considerations for the Clinical and Research Use of Transcranial Direct Current Stimulation (tDCS): review and recommendations from an expert panel. Fregni F, Nitsche MA, Loo CK, Brunoni AR, Marangolo P, Leite J, Carvalho S, Bolognini N, Caumo W, Paik NJ, Simis M, Ueda K, Ekhitari H, Luu P, Tucker DM, Tyler WJ, Brunelin J, Datta A, Juan CH, Venkatasubramanian G, Boggio PS, Bikson M. Clin Res Regul Aff. 2015 Mar 1;32(1):22-35. PMID: 25983531

*Exceptions: BrainStimulator tDCS Device